Multiple Sclerosis Clinical Trial 2015-014

[LCID Study Number: 2015-014]

Plegridy (Peginterferon ß-1a) Real World Effectiveness and Safety Observational Program

The purpose of this observational study is to find out more about the long-term safety and effectiveness of PLEGRIDY in patients with Multiple Sclerosis over approximately a five year time period.

Disease/Condition: Multiple Sclerosis

Department: Neurology

Status: Active, Not Recruiting

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Lexington

Primary Contact Email: [email protected]

Protocol #: 2015-014
Principal Investigator(s): Ann Camac
Study Coordinator(s): Melissa Dunbar
Trial Phase: Sponsor Initiated Study Observational